Lucence’s LiquidHALLMARK Sequencing-based Liquid Biopsy Assay Expands to Include cfRNA

January 12, 2022 Leave a comment 1,272 Views

Lucence, a precision oncology company using liquid biopsy to bring clarity to cancer care, is announcing the availability of an expanded version of its...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: Lucence

Lucence’s LiquidHALLMARK Sequencing-based Liquid Biopsy Assay Expands to Include cfRNA

Wistar scientists use RNA-Seq to identify esophageal cancer biomarkers

Narrowing numerous nascent RNA-sequencing strategies

RNA Sequencing – A New Genomic Tool Entering the Clinic

Dividing out quantification uncertainty allows efficient assessment of differential transcript expression with edgeR

Ex vivo tissue perturbations coupled to single-cell RNA-seq reveal multilineage cell circuit dynamics

Cell-type-specific genetic risk contributes to distinct stages of Alzheimer’s disease progression

Applying spatial transcriptomics in plants